ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00215982
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : November 25, 2013
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by:
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2007
  Actual Study Completion Date : July 2007